ALNOV.PA
Novacyt SA
Price:  
0.46 
EUR
Volume:  
81,850.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALNOV.PA EV/EBITDA

-528.0%
Upside

As of 2025-10-18, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -1.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 20.01 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -13.69 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.0x - 9.4x 9.0x
Forward P/E multiples 11.3x - 15.0x 13.4x
Fair Price (2.00) - (1.64) (1.99)
Upside -531.5% - -453.8% -528.0%
0.46 EUR
Stock Price
(1.99) EUR
Fair Price

ALNOV.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-10-15 -1.50
2025-10-14 -1.45
2025-10-13 -1.54
2025-10-10 -1.55
2025-10-09 -1.50
2025-10-08 -1.49
2025-10-07 -1.53
2025-10-06 -1.46
2025-10-03 -1.52
2025-10-02 -1.56
2025-10-01 -1.57
2025-09-30 -1.53
2025-09-29 -1.57
2025-09-26 -1.40
2025-09-25 -1.50
2025-09-24 -1.43
2025-09-23 -1.46
2025-09-22 -1.48
2025-09-19 -1.44
2025-09-18 -1.40
2025-09-17 -1.45
2025-09-16 -1.46
2025-09-15 -1.50
2025-09-12 -1.45
2025-09-11 -1.51
2025-09-10 -1.54
2025-09-09 -1.36
2025-09-08 -1.38
2025-09-05 -1.40
2025-09-04 -1.42
2025-09-03 -1.39
2025-09-02 -1.40
2025-09-01 -1.46
2025-08-29 -1.52
2025-08-28 -1.51
2025-08-27 -1.51
2025-08-26 -1.47
2025-08-25 -1.56
2025-08-22 -1.51
2025-08-21 -1.54
2025-08-20 -1.48
2025-08-19 -1.52
2025-08-18 -1.57
2025-08-15 -1.51
2025-08-14 -1.60
2025-08-13 -1.76
2025-08-12 -1.36
2025-08-11 -1.35
2025-08-08 -1.35
2025-08-07 -1.38